ChemoPower Series B Fundraising Announcement

ChemoPower Technology Pte. Ltd. has started a Series B fundraising process to raise up to US$20 million. The Company will focus on designing and controlling the quality of the natural products.

ChemoPower has appointed Mita Securities Global Consulting Pte. Ltd. (“MSGC”) as the dedicated consultant and advisor for Business Development Strategy, as it scouts for strategic and financial partners.

MSGC is a consulting and advisory firm based in Singapore, fully owned by Mita Securities Co., Ltd. (Japan). Leveraging on the professional reputation and robust relationships Mita Securities Co., Ltd. has built over its 70-years of history, MSGC is in a unique position to introduce proprietary investment opportunities into Asia and the rest of the world.

—- Contact: —-
Mita Securities Global Consulting Pte. Ltd.  (Singapore)
105 Cecil Street #24-02 The Octagon, Singapore 069534
URL:https://mitasec.com/MSGC/en/
E-mail:msgc_info@mitasec.com

—————————-

分子信息公司(ChemoPower)已启动B轮融资,最多融资2000万美元。分子信息公司将专注于设计和控制天然产品的质量。

分子信息公司已委任Mita Securities Global Consulting Pte. Ltd. (以下简称 “MSGC”)作为分子信息公司业务发展战略的专门顾问和咨询公司,为公司寻找战略和财务合作伙伴。

MSGC是一家设在新加坡的咨询和顾问公司,由日本三田证券株式会社(Mita Securities Co., Ltd. )全资拥有。凭借三田证券株式会社70多年来建立的专业声誉和良好的关系,MSGC在将专有投资机会引入亚洲和世界其他地区方面具有独特的优势。

—- 联系人:—-
Mita Securities Global Consulting Pte. Ltd. (新加坡)
105 Cecil Street #24-02 The Octagon, Singapore 069534
网址:https://mitasec.com/MSGC/en/
电子邮件:msgc_info@mitasec.com

Comments are closed.